A 6-month large-scale study into the safety of tamsulosin - Wikidata - awgldk - TriplyDB

A 6-month large-scale study into the safety of tamsulosin

A 6-month large-scale study into the safety of tamsulosin

http://www.wikidata.org/entity/Q28367575

about

Tamsulosin for benign prostatic hyperplasia Tamsulosin for benign prostatic hyperplasia.Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular system.Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms.Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin Selectivity of pharmacological tools: implications for use in cell physiology. A review in the theme: Cell signaling: proteins, pathways and mechanisms.Tamsulosin-induced severe hypotension during general anesthesia: a case report.Tamsulosin induced diarrhea: a case report.

P2860

Q24234556-B1DAE8D3-A2F4-465C-8497-AE829DEDB6C6 Q30882035-15CEC3DD-B781-4221-9AF8-8FE62687FF21 Q36116539-A3E9DE04-1490-46AD-A95E-8D5906C1C169 Q38235157-E5A0D27F-EFED-4857-A9B5-7580F4DE4097 Q38264945-CF4A1E37-4832-4F7C-91FF-5166946C548B Q38336214-DA4056C6-A7AA-4143-A72D-6F4408871706 Q41127474-FB02A071-88C7-46FF-A7FD-A01D53F7BCC0 Q47161387-D6288C52-31F6-4FDB-A212-082780C557F7

P2860

A 6-month large-scale study into the safety of tamsulosin

http://www.wikidata.org/entity/Q28367575

description

2001 nî lūn-bûn

@nan

2001 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

A 6-month large-scale study into the safety of tamsulosin

@ast

A 6-month large-scale study into the safety of tamsulosin

@en

A 6-month large-scale study into the safety of tamsulosin

@nl

type

label

A 6-month large-scale study into the safety of tamsulosin

@ast

A 6-month large-scale study into the safety of tamsulosin

@en

A 6-month large-scale study into the safety of tamsulosin

@nl

prefLabel

A 6-month large-scale study into the safety of tamsulosin

@ast

A 6-month large-scale study into the safety of tamsulosin

@en

A 6-month large-scale study into the safety of tamsulosin

@nl

P1433

Q28367575-DC0337C3-2D0A-4EB0-B175-F7854322C769

P1476

Q28367575-33A5EED1-56A9-4CDD-A36B-13FC6569379E

P2093

Q28367575-0A1A8C47-CC23-427D-A6A6-03C0E53821AC

Q28367575-659E6083-EABB-48AD-BA1B-E2342F9B6AD1

Q28367575-683F1F6D-486E-48F4-BE5F-14D94E9A6926

Q28367575-FD1A216F-7633-45C1-899C-E0B84E955FFF

P2860

Q28367575-004971CB-B89C-4550-B28B-9AF3744818F6

Q28367575-19EB32A2-8EE9-4FCD-8A07-CD6BC1DD5ACA

Q28367575-1A9603C8-F605-443D-A62F-E878B15B6210

Q28367575-211E9421-2F75-4A9F-9286-670B65769D05

Q28367575-25F8588E-2369-41A8-9AFB-D90641A9B644

Q28367575-2D0C915B-9421-472A-B30B-74DCF64D0308

Q28367575-3D089E47-9628-4108-A144-075EAAB22CAA

Q28367575-41F876A9-F79B-47A2-A750-AE69873E4F30

Q28367575-811B5A7C-1CC1-4904-9F74-FF151F7F2674

Q28367575-8C9F4A7C-6AC1-47D2-914B-5510CF59E94E

P304

Q28367575-7F5C2888-1C06-4E5F-BE8C-59067F177B7B

P31

Q28367575-948D9EBE-FD09-48EC-B59E-1D3B9955485F

P356

Q28367575-F974602C-410E-4096-839C-FA9E87C3ADE6

P407

Q28367575-32C16617-6B67-43B8-9E09-13061CAD0F1B

P433

Q28367575-4E96B3A3-CD9D-41A1-B514-F2B548DB8778

P478

Q28367575-5F6630EF-09B7-494C-B447-ACA12E0821E8

P577

Q28367575-9FCE95F4-FB56-414B-BB89-7475BC6EF3DF

P5875

Q28367575-0D3FD428-1465-45D1-8F05-5148D9DD2734

P698

Q28367575-67F64383-BC84-4A4F-AFB2-D9C94254DAFA

P932

Q28367575-2ACA1075-E460-494A-81AB-AE35F2A23285

P356

J.0306-5251.2001.01388.X

P1433

British Journal of Clinical Pharmacology

P1476

A 6-month large-scale study into the safety of tamsulosin

@en

P2093

H Rübben

http://www.w3.org/2001/XMLSchema#string

H U Bressel

http://www.w3.org/2001/XMLSchema#string

M C Michel

http://www.w3.org/2001/XMLSchema#string

M Goepel

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

Adverse effects of alpha 1-adrenergic blocking drugs.

Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. A meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group.

A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing.

The pharmacovigilance of tamsulosin: event data on 12484 patients.

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

Endocrine and adrenergic pharmacological intervention in diseases of the prostate

Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.

Tamsulosin : A Review of its Pharmacological Properties and Therapeutic Potential in the Management of Symptomatic Benign Prostatic Hyperplasia.

Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin.

P304

609-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.0306-5251.2001.01388.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11918489

http://www.w3.org/2001/XMLSchema#string

P698

11422021

http://www.w3.org/2001/XMLSchema#string

P932

2014481

http://www.w3.org/2001/XMLSchema#string